Abstract: The present invention provides liposomal L-carnitine formulations and methods for the treatment of intermittent claudication. The formulation is optimized with respect to L-carnitine transport through skin in vitro. Preferably, the formulation is a topical cream for the administration of the drug directly on the muscle group that is most affected by the poor local blood flow.
Abstract: A new method of producing liposomes is described using an in-line mixing system. The liposomes produced by this method find utility in numerous therapeutic applications.
Abstract: The present invention provides liposomal formulations comprising a lipid vesicle and at least one single chain lipid active agent. In addition, the present invention provides methods for using the same for preventing an infection in a mammal.
Type:
Application
Filed:
March 12, 2004
Publication date:
May 5, 2005
Applicants:
OPTIME Therapeutics, Inc., Megee-Womens Health Corporation
Abstract: A new method of producing liposomes is described using an in-line mixing system. The liposomes produced by this method find utility in numerous therapeutic applications.
Abstract: A new method of producing liposomes is described using an in-line mixing system. The liposomes produced by this method find utility in numerous therapeutic applications.
Abstract: The present invention provides, inter alia, novel, liposome-based formulations for enhanced ophthalmic drug delivery. Such ophthalmic drug formulations are useful for treating ocular inflammation stemming from, for example, iritis, conjunctivitis, seasonal allergic conjunctivitis, acute and chronic endophthalmitis, anterior uveitis, uveitis associated with systemic diseases, posterior segment uveitis, chorioretinitis, pars planitis, masquerade syndromes including ocular lymphoma, pemphigoid, scleritis, keratitis, severe ocular allergy, corneal abrasion, or blood-aqueous barrier disruption, and for treating post-operative ocular inflammation, resulting from, for example, photorefractive keratectomy, cataract removal surgery, intraocular lens implantation or radial keratotomy.
Type:
Application
Filed:
November 13, 2003
Publication date:
November 11, 2004
Applicant:
OPTIME Therapeutics, Inc.
Inventors:
Hans Hofland, Juiiet Bongianni, Tobias Wheeler
Abstract: A new method of producing liposomes is described using an in-line mixing system. The liposomes produced by this method find utility in numerous therapeutic applications.
Abstract: A new method of producing liposomes is described using an in-line mixing system. The liposomes produced by this method find utility in numerous therapeutic applications.